AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

PIOGLITAZONE

12 registrations across 6 African markets— 9 active

Markets with PIOGLITAZONE

Recent registrations

Brand / ProductMarketHolderStatusExpires
PIOGLITAZONE HYDROCHLORIDE TABLETS MACLEODS 30 mg🇿🇦South AfricaMacleods Pharmaceuticals SA (Pty) LtdactiveMay 2029
LG GLIZONE TABLET (Each tablet contains Pioglitazone 15mg)🇬🇭GhanaactiveApr 2027
LG GLIZONE TABLET (Each tablet contains Pioglitazone 15mg)🇬🇭GhanaactiveApr 2027
PLUTONE-30 TABLET
TABLETSX3X10
🇳🇬NigeriaL'PACEMAKER PHARM LTD. PLOT 11expiredJan 2021
PIAGTOS
Comprimé / 30 mg
🇹🇳TunisiaTERIAKexpiredAug 2009
PIAGTOS
Comprimé / 15 MG
🇹🇳TunisiaTERIAKexpiredJun 2008
PIOGLITAZONE
Oral Solid Ordinary Tablets
🇺🇬UgandaGETZ PHARMA PVT LIMITEDactive
PIONORM
comprimé / 15 mg
🇸🇳SenegalMICROLABS LIMITEDactive
PIONORM
comprimé / 30 mg
🇸🇳SenegalMICROLABS LIMITEDactive
PIOGLITAZONE
Oral Solid Ordinary Tablets
🇺🇬UgandaGETZ PHARMA PVT LIMITEDactive
PIOGLITAZONE
Oral Solid Ordinary Tablets
🇺🇬UgandaGETZ PHARMA PVT LIMITEDactive
PIOGLITAZONE
Oral Solid Ordinary Tablets
🇺🇬UgandaGETZ PHARMA PVT LIMITEDactive

PIOGLITAZONE in Africa — Regulatory Overview

PIOGLITAZONE is registered across 6 African markets with 12 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Uganda, Ghana, Senegal, Tunisia and 2 more. AfricaRegulatory refreshes this data daily from official government sources.

Of the 12 registrations, 9 (75%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.